Deck 25: Lipid-Lowering Drugs and Atherosclerosis

Full screen (f)
exit full mode
Question
When a patient is intolerant to statin class drugs, the most common second choice for treating LDL cholesterol levels greater than 135 mg/dl is:

A) Bile acid sequestrants
B) Fibric acid derivatives
C) Cholesterol absorption inhibitors
D) Niacin
E) Statins
Use Space or
up arrow
down arrow
to flip the card.
Question
Isolated hypertriglyceridemia is best treated with:

A) Statins
B) Fibric acid derivatives
C) Cholesterol absorption inhibitors
D) Niacin
E) Bile acid sequestrants
Question
Vytorin is a combination of ezetimibe and simvastatin. The pharmacologic effects include:

A) Platelet inhibition
B) Reduction in intestinal absorption of cholesterol
C) Cholesterol-lowering ability independent of plasma lipoprotein levels
D) Inhibition in cholesterol synthesis within hepatocytes
E) A, B, and D
Unlock Deck
Sign up to unlock the cards in this deck!
Unlock Deck
Unlock Deck
1/3
auto play flashcards
Play
simple tutorial
Full screen (f)
exit full mode
Deck 25: Lipid-Lowering Drugs and Atherosclerosis
When a patient is intolerant to statin class drugs, the most common second choice for treating LDL cholesterol levels greater than 135 mg/dl is:

A) Bile acid sequestrants
B) Fibric acid derivatives
C) Cholesterol absorption inhibitors
D) Niacin
E) Statins
Fibric acid derivatives
Isolated hypertriglyceridemia is best treated with:

A) Statins
B) Fibric acid derivatives
C) Cholesterol absorption inhibitors
D) Niacin
E) Bile acid sequestrants
Fibric acid derivatives
Vytorin is a combination of ezetimibe and simvastatin. The pharmacologic effects include:

A) Platelet inhibition
B) Reduction in intestinal absorption of cholesterol
C) Cholesterol-lowering ability independent of plasma lipoprotein levels
D) Inhibition in cholesterol synthesis within hepatocytes
E) A, B, and D
A, B, and D
locked card icon
Unlock Deck
Unlock for access to all 3 flashcards in this deck.